Psyence Biomedical (PBM) Price to Earnings (2023 - 2026)

Psyence Biomedical (PBM) Price to Earnings (2023 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	P/E
1	Genmab A	276,399.99 Bn	276,398.47 Bn	831.00 Mn	23,313.09
2	Akari Therapeutics	1,217.26 Bn	1,217.26 Bn	-	-41,513.52
3	BeOne Medicines	419.38 Bn	414.59 Bn	1.35 Bn	817.47
4	Vertex Pharmaceuticals	126.54 Bn	119.30 Bn	2.59 Bn	29.17
5	Pharming	110.17 Bn	110.12 Bn	65.80 Mn	-7,229.82
6	Regeneron Pharmaceuticals	64.97 Bn	56.22 Bn	3.31 Bn	14.69
7	Argenx Se	56.44 Bn	56.44 Bn	1.18 Bn	37.90
8	Alnylam Pharmaceuticals	40.09 Bn	37.08 Bn	959.66 Mn	73.70
9	Revolution Medicines	37.15 Bn	37.15 Bn	-	-27.08
10	Psyence Biomedical	1.72 Mn	1.72 Mn	-	-4.92

Download Data